Elucidation of mechanism of disease resistance and persistence in chronic myeloid leukemia.
Chronic myeloid leukemia (CML) is a clonal disorder of the hematopoietic stem cell caused by the BCR-ABL receptor tyrosine kinase. Imatinib mesylate (IM) is an inhibitor of BCR-ABL and has been approved for the treatment of CML. IM is well tolerated and highly efficacious as it induces stable long-t...
Sparad:
Huvudupphovsman: | |
---|---|
Övriga upphovsmän: | |
Materialtyp: | Dissertation |
Språk: | engelska |
Publicerad: |
Philipps-Universität Marburg
2011
|
Ämnen: | |
Länkar: | PDF-fulltext |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|
No citations were found for this record.